Why signal?
• Improved usage of the drug • Improved usage of the drug • More benefit, less harm to patients What should be achieved?
• Signals should not be missed • Signals should not be missed • Signals should be found early • 'False' signals should be kept to a minimum
Steps in Signal Detection
• • Reporting rate for ADR is higher for drug A than for • Reporting rate for ADR is higher for drug A than for comparator • Does this mean the incidence of ADR is higher for drug A than for comparator? • The reporting of rhabdomyolysis is greater for cerivastatin than for other statins -the natural history of the disease under treatment -the background incidence of the reaction the public health context -the public health context
